| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2025 | 6 Feb 2025 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31 2024 amongst other routine matters. Unaudited Financial Results For the Quarter and Nine Months Ended December 31, 2024 (As Per BSE Announcement Dated on: 12/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 8 Nov 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve and take on record the un-audited financial results for the quarter and half year ended September 30 2024 amongst other routine matters. Submission of unaudited financial results of the Company and Limited review report for Quarter and Half Year Ended September 30, 2024 (As per BSE Announcement Dated on 14/11/2024) | ||
| Board Meeting | 14 Aug 2024 | 9 Aug 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the un-audited Financial Results/Statements for the quarter ended June 30 2024 and other business items Un-Audited Financial Results for the Quarter Ended on 30.06.2024 (As Per BSE Announcement dated on 14.08.2024) | ||
| Board Meeting | 30 May 2024 | 24 May 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited financial results/statements for the quarter and year ended on 31st March 2024 Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Thursday 30th May, 2024 Financial results for the Quarter and year ended on 31st March 2024 (As Per BSE Announcement Dated on 30.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
